WhitTier Trust Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.58M | Sell |
7,668
-55
| -0.7% | -$10.5K | 0.03% | 251 |
|
|
2026
Q1 | $1.33M | Buy |
7,723
+15
| +0.2% | +$2.76K | 0.03% | 268 |
|
|
2025
Q4 | $1.41M | Sell |
7,708
-13
| -0.2% | -$2.12K | 0.03% | 262 |
|
|
2025
Q3 | $1.23M | Sell |
7,721
-25
| -0.3% | -$3.38K | 0.03% | 275 |
|
|
2025
Q2 | $973K | Hold |
7,746
| – | – | 0.02% | 315 |
|
|
2025
Q1 | $1.06M | Sell |
7,746
-86
| -1% | -$12.3K | 0.03% | 298 |
|
|
2024
Q4 | $1.2M | Sell |
7,832
-77
| -1% | -$13K | 0.03% | 272 |
|
|
2024
Q3 | $1.53M | Sell |
7,909
-67
| -0.8% | -$14K | 0.04% | 248 |
|
|
2024
Q2 | $1.85M | Sell |
7,976
-20
| -0.3% | -$4.35K | 0.05% | 224 |
|
|
2024
Q1 | $1.72M | Buy |
7,996
+66
| +0.8% | +$15.5K | 0.05% | 235 |
|
|
2023
Q4 | $2.05M | Sell |
7,930
-837
| -10% | -$206K | 0.07% | 217 |
|
|
2023
Q3 | $2.25M | Buy |
8,767
+36
| +0.4% | +$9.63K | 0.08% | 194 |
|
|
2023
Q2 | $2.49M | Hold |
8,731
| – | – | 0.08% | 189 |
|
|
2023
Q1 | $2.43M | Buy |
8,731
+191
| +2% | +$52.8K | 0.09% | 183 |
|
|
2022
Q4 | $2.36M | Sell |
8,540
-12
| -0.1% | -$3.39K | 0.09% | 181 |
|
|
2022
Q3 | $2.28M | Sell |
8,552
-150
| -2% | -$31.9K | 0.1% | 185 |
|
|
2022
Q2 | $1.77M | Buy |
8,702
+93
| +1% | +$19K | 0.07% | 213 |
|
|
2022
Q1 | $1.81M | Hold |
8,609
| – | – | 0.07% | 222 |
|
|
2021
Q4 | $2.06M | Sell |
8,609
-10
| -0.1% | -$2.57K | 0.08% | 202 |
|
|
2021
Q3 | $2.44M | Buy |
8,619
+59
| +0.7% | +$19.3K | 0.1% | 168 |
|
|
2021
Q2 | $2.96M | Sell |
8,560
-536
| -6% | -$162K | 0.12% | 151 |
|
|
2021
Q1 | $2.54M | Sell |
9,096
-126
| -1% | -$34K | 0.11% | 154 |
|
|
2020
Q4 | $2.26M | Sell |
9,222
-44
| -0.5% | -$11.4K | 0.11% | 162 |
|
|
2020
Q3 | $2.63M | Hold |
9,266
| – | – | 0.15% | 135 |
|
|
2020
Q2 | $2.48M | Sell |
9,266
-402
| -4% | -$121K | 0.16% | 129 |
|
|
2020
Q1 | $3.06M | Buy |
9,668
+18
| +0.2% | +$5.46K | 0.24% | 99 |
|
|
2019
Q4 | $2.86M | Sell |
9,650
-294
| -3% | -$81.6K | 0.18% | 117 |
|
|
2019
Q3 | $2.31M | Sell |
9,944
-3,499
| -26% | -$815K | 0.16% | 122 |
|
|
2019
Q2 | $3.14M | Sell |
13,443
-819
| -6% | -$189K | 0.22% | 105 |
|
|
2019
Q1 | $3.37M | Buy |
14,262
+29
| +0.2% | +$9.13K | 0.25% | 101 |
|
|
2018
Q4 | $4.28M | Buy |
14,233
+84
| +0.6% | +$26.8K | 0.35% | 76 |
|
|
2018
Q3 | $5M | Buy |
14,149
+65
| +0.5% | +$22.4K | 0.36% | 75 |
|
|
2018
Q2 | $4.09M | Buy |
14,084
+115
| +0.8% | +$32.3K | 0.32% | 83 |
|
|
2018
Q1 | $3.83M | Sell |
13,969
-2,023
| -13% | -$628K | 0.31% | 84 |
|
|
2017
Q4 | $5.09M | Buy |
15,992
+265
| +2% | +$85K | 0.44% | 66 |
|
|
2017
Q3 | $4.92M | Buy |
15,727
+14
| +0.1% | +$4.15K | 0.46% | 64 |
|
|
2017
Q2 | $4.26M | Sell |
15,713
-33
| -0.2% | -$8.73K | 0.41% | 70 |
|
|
2017
Q1 | $4.3M | Buy |
15,746
+264
| +2% | +$74.6K | 0.43% | 69 |
|
|
2016
Q4 | $4.39M | Buy |
15,482
+8,013
| +107% | +$2.38M | 0.47% | 65 |
|
|
2016
Q3 | $2.34M | Sell |
7,469
-243
| -3% | -$72K | 0.27% | 91 |
|
|
2016
Q2 | $1.86M | Sell |
7,712
-36
| -0.5% | -$9.49K | 0.21% | 109 |
|
|
2016
Q1 | $2.02M | Sell |
7,748
-635
| -8% | -$168K | 0.24% | 104 |
|
|
2015
Q4 | $2.57M | Buy |
8,383
+925
| +12% | +$266K | 0.3% | 79 |
|
|
2015
Q3 | $2.18M | Buy |
7,458
+6,458
| +646% | +$2.13M | 0.27% | 87 |
|
|
2015
Q2 | $404K | Buy |
1,000
+125
| +14% | +$50.2K | 0.04% | 277 |
|
|
2015
Q1 | $369K | Hold |
875
| – | – | 0.04% | 291 |
|
|
2014
Q4 | $297K | Hold |
875
| – | – | 0.03% | 313 |
|
|
2014
Q3 | $289K | Hold |
875
| – | – | 0.03% | 298 |
|
|
2014
Q2 | $276K | Hold |
875
| – | – | 0.03% | 299 |
|
|
2014
Q1 | $268K | Hold |
875
| – | – | 0.03% | 300 |
|
|
2013
Q4 | $245K | Hold |
875
| – | – | 0.03% | 309 |
|
|
2013
Q3 | $211K | Hold |
875
| – | – | 0.03% | 317 |
|
|
2013
Q2 | $188K | Buy |
+875
| New | +$187K | 0.03% | 320 |
|
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
WhitTier Trust Company's BIIB Position: Q2 2026 in Review
WhitTier Trust Company reduced its Biogen (BIIB) stake by 0.71% in Q2 2026, selling an estimated $10.5K and leaving 7,668 shares worth $1.58M. The position accounts for 0.03% of the portfolio, ranked #251.
WhitTier Trust Company first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.09M in Q4 2017. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- WhitTier Trust Company held 7,668 shares of Biogen worth $1.58M as of Q2 2026.
- WhitTier Trust Company sold 55 Biogen shares in Q2 2026, an estimated $10.5K.
- Biogen made up 0.03% of WhitTier Trust Company's portfolio in Q2 2026, its #251 holding.
- WhitTier Trust Company first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- WhitTier Trust Company's Biogen position peaked at $5.09M in Q4 2017.
- 380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.